Find information on common issues.
Ask questions and find answers from other users.
Suggest a new site feature or improvement.
Check on status of your tickets.
Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials. More information on Nanomedicine can be found here.
Building Molecules for Function: New Materials & Inks Will Be Needed If Additive Manufacturing Will Change Medicine
27 Feb 2019 | | Contributor(s):: Matthew L. Becker
This presentation will describe the use of several translationally relevant chemistries and post-printing functionalization strategies that are impacting the practice of medicine and how physicians are planning for future therapies that were not possible previously.
Tech Intersection: Understanding the Bio and Nano Link
23 Jan 2018 | | Contributor(s):: Christie M. Sayes, NACK Network
Outline:The application (medicine and engineering) and implication (human health and environmental toxicology) of the Nano-Bio InterfacePart 1: Introduction to the fields of nanomedicine and nanotoxicologyPart 2: Commercialization case studies
Soft, Biocompatible Optoelectronic Interfaces to the Brain
08 Jun 2017 | | Contributor(s):: John A. Rogers
In this talk, we will describe foundational concepts in physics and materials science for these types of technologies, in 1D, 2D and 3D architectures. Examples in system level demonstrations include experiments on freely moving animals with ‘cellular-scale’, injectable optofluidic...
Tissue-Level Communication Through Patterning Of Intercellular Ca2+ Wave Dynamics
22 Nov 2016 | | Contributor(s):: Jeremiah J. Zartman
Here we characterize periodic intercellular Ca2+ waves (ICWs) in a model organ system of epithelial growth and patterning—the Drosophila wing imaginal disc. We developed a novel regulated environment for micro-organs (REM-Chip) device that enable a broad range of genetic, chemical and...
Informatics Tool to Explore the Nanomaterial-Biological Interactions Knowledgebase
11 Apr 2016 | | Contributor(s):: Sandra Karcher
Welcome to the resource: Informatics Tool to Explore the Nanomaterial-Biological Interactions Knowledgebase! N4mics was developed to enable cross-study exploration of the NBI Knowledgebase with the goal of identifying relationships between nanomaterial characteristics and biological responses....
[Illinois] Translational Nanomedicine from Drug Discovery to Preclinical Studies
10 Nov 2015 | | Contributor(s):: Dipanjan Pan
[Illinois] Translational Nanomedicine in the Interface of Chemistry, Biology, and Engineering
26 Aug 2014 | | Contributor(s):: Dipanjan Pan
[Illinois] Plasmonic Engineering in Nanomedicine
28 Apr 2014 | | Contributor(s):: Srikanth Singamaneni
Plasmonics involves the control of light at the nanoscale using surface plasmons. One particular area where plasmonics is expected to make an enoromous impact is the field of life sciences, with applications in bioimaging, biosensing, and targted and externally-triggered therapy. In the first...
Summary of Companies Approved by FDA, Who Use Gold Nanoparticles in Invitro Diagnosis
22 Dec 2012 | | Contributor(s):: VEERA CSR CHITTEPU
Application of Dynamic Light Scattering in the Physicochemical Characterization of Natural and Engineered Nanoparticles
20 Apr 2012 | | Contributor(s):: Trisha Eustaquio
This presentation will highlight the use of dynamic light scattering (DLS), which measures the hydrodynamic size of nanoparticles in suspension, in characterizing specific examples of engineered and natural nanoparticles. In terms of engineered nanoparticles, the role of nanoparticle size in...
The Importance of Zeta Potential for Drug/Gene Delivery in Nanomedicine
11 Apr 2012 | | Contributor(s):: James Leary
Finding a Needle in a Haystack: Nanobarcoding for Single Nanoparticle Detection in in vitro and ex vivo Nanomedical Biodistribution Studies
14 Feb 2012 | | Contributor(s):: Trisha Eustaquio
Determination of the fate of administered nanoparticles in a biological system, or nanoparticle biodistribution, is critical in evaluating a nanoparticle formulation for nanomedical purposes. Unlike their small-molecule drug antecedents, nanoparticles pose unique challenges in the design of...
Illinois Nano EP Seminar Series Spring 2011: Interfacing Engineering, Biology, and Medicine at the Micro and Nano Scale
13 Dec 2011 | | Contributor(s):: Rashid Bashir
In this talk, we will present an overviewof our work in Silicon-Based BioMEMS and Bionanotechnology and discuss the state of the art and thefuture challenges and opportunities. We will review a range of projects in our group focused towardsdeveloping rapid detection of biological entities and...
KIST/PU Advances in detection systems for biology: Classifying signals from fluorescence and scatter
out of 5 stars
08 Dec 2011 | | Contributor(s):: J. Paul Robinson
Biology-driven advances in photonic detection systems have been dramatic in the last several years. Three specific aspects are of particular interest: molecular detection, cellular detection, and whole-organ or small-animal imaging. Each area of study requires specific probes, detectors, and...
KIST/PU Nanostructured Heparin Derivatives as an Angiogenesis Inhibitor
07 Dec 2011 | | Contributor(s):: Youngro Byun
Although low molecular weight heparin (LMWH) has been known to regulate angiogenesis, tumor growth and metastasis, the administration of heparin for treating cancer is limited in clinical application due to its unsatisfactory therapeutic effects and a strong anticoagulant activity, which induces...
KIST/PU 6th Annual Symposium: High Impact Research to Society
07 Dec 2011 |
In 2006, the South Korean Ministry of Science and Technology selected the KIST and Purdue team project from 20 international research proposals submitted to examine how to learn more about the molecular makeup of diseases.
KIST/PU The Professor’s Challenge: To commercialize or not, that is the question?
06 Dec 2011 | | Contributor(s):: J. Paul Robinson
Outline:Outline the Professors DilemmaShow what the normal criteria for research project direction isDiscuss the Corporate perspectiveDiscuss an example of failed innovationDemonstrate how time can impact an innovative ideaConclusions
KIST/PU Designing a Research Program Around Unmet Clinical Needs
06 Dec 2011 | | Contributor(s):: Alyssa Panitch
KIST/PU Theragnosis – A New Paradigm of Personalized Medicine
06 Dec 2011 | | Contributor(s):: Ick Chan Kwon
Companion Diagnosis, based on pharmacogenomics, has been recognized as one of most important key representatives of personalized medicine. However, Companion Diagnosis does not provide any clues in developing new ways of therapeutics but it only provides a best choice of drugs based on given...
Illinois BioNanotechnology Seminar Series Fall 2011: Precisely Size Controlled Drug-silica Nanoconjugate for Cancer Therapy
05 Dec 2011 | | Contributor(s):: Li Tang
Drug delivery nanomedicine, exemplified by micelles and nanoparticles roughly in the size range of 1-200 nm, have attracted much interest in the past 2-3 decades as alternative modalities for cancer treatment. The size of these drug delivery vehicles has been strongly correlated with their in...